CFM
UTHR icon

Catalyst Funds Management’s United Therapeutics UTHR Stock Holding History

Catalyst Funds Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$781K Buy
+1,441
New +$812K 0.04% 331
2026
Q1 		– Sell
-1,240
Closed -$604K – 717
2025
Q4 		$604K Buy
1,240
+40
+3% +$18.6K 0.14% 153
2025
Q3 		$503K Buy
+1,200
New +$404K 0.08% 236
2024
Q4 		– Sell
-300
Closed -$108K – 1232
2024
Q3 		$108K Buy
+300
New +$101K 0.02% 479

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Catalyst Funds Management's UTHR Position: Q2 2026 in Review

Catalyst Funds Management opened a new position in United Therapeutics (UTHR) in Q2 2026: 1,441 shares worth $781K. The stake represents 0.04% of the portfolio and ranks #331 among its holdings. This is a return to the name: Catalyst Funds Management previously reported a position in UTHR as recently as Q4 2025.

Catalyst Funds Management first reported a position in UTHR in Q3 2024 and has held it in 4 quarters since. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Catalyst Funds Management held 1,441 shares of United Therapeutics worth $781K as of Q2 2026.
  • United Therapeutics was a new Catalyst Funds Management position in Q2 2026.
  • United Therapeutics made up 0.04% of Catalyst Funds Management's portfolio in Q2 2026, its #331 holding.
  • Catalyst Funds Management first reported a position in United Therapeutics in Q3 2024 and has held it in 4 quarters since.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Catalyst Funds Management's 13F filing for Q2 2026, filed 10 Aug 2026.